×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share
3850 views

Modérateur : Alexandre de Nonneville

Au programme de cette soirée

18:00 Introduction
 
18:05 Traitements de première ligne - études immuno, statut PDL1...
Fanny Le Du
 
18:25 La place des anticorps conjugués à ce jour - accès précoces actuels et utilisation pratique (tolérance, sécurité)
Marie Beguinot
 
18:45 ADC : un développement exponentiel et la remontée des lignes
Thomas Grinda
 
19:05 Résistances aux ADC, données actuelles et perspectives
Alexandre de Nonneville
 
19:25 Débat/discussion - Réponses aux questions
 

 


Webinar #2   Webinar #3

 

Shooting date : 2024-01-18
Last update : 2024-04-03

Suggestions

Tuesday, February 4th 2025 from 06pm to 07:30pm (GMT+1)
Honolulu : Tuesday, February 4th 2025 from 06am to 07:30am (GMT+1)
San Francisco : Tuesday, February 4th 2025 from 08am to 09:30am (GMT+1)
New York : Tuesday, February 4th 2025 from 11am to 12:30pm (GMT+1)
Buenos Aires : Tuesday, February 4th 2025 from 01pm to 02:30pm (GMT+1)
London / Dublin : Tuesday, February 4th 2025 from 04pm to 05:30pm (GMT+1)
Paris / Berlin : Tuesday, February 4th 2025 from 05pm to 06:30pm (GMT+1)
Istanbul : Tuesday, February 4th 2025 from 06pm to 07:30pm (GMT+1)
Moscou / Dubaï : Tuesday, February 4th 2025 from 08pm to 09:30pm (GMT+1)
Bangkok : Tuesday, February 4th 2025 from 11pm to 12:30am (GMT+1)
Shanghai : Wednesday, February 5th 2025 from 12am to 01:30am (GMT+1)
Tokyo : Wednesday, February 5th 2025 from 01am to 02:30am (GMT+1)
Sydney : Wednesday, February 5th 2025 from 02am to 03:30am (GMT+1)
Wellington : Wednesday, February 5th 2025 from 04am to 05:30am (GMT+1)

Prise en charge du cancer du sein métastatique HER2 surexprimé

Share
Tuesday, March 19th 2024 from 06pm to 07:30pm (GMT+1)
Honolulu : Tuesday, March 19th 2024 from 06am to 07:30am (GMT+1)
San Francisco : Tuesday, March 19th 2024 from 08am to 09:30am (GMT+1)
New York : Tuesday, March 19th 2024 from 11am to 12:30pm (GMT+1)
Buenos Aires : Tuesday, March 19th 2024 from 01pm to 02:30pm (GMT+1)
London / Dublin : Tuesday, March 19th 2024 from 04pm to 05:30pm (GMT+1)
Paris / Berlin : Tuesday, March 19th 2024 from 05pm to 06:30pm (GMT+1)
Istanbul : Tuesday, March 19th 2024 from 06pm to 07:30pm (GMT+1)
Moscou / Dubaï : Tuesday, March 19th 2024 from 08pm to 09:30pm (GMT+1)
Bangkok : Tuesday, March 19th 2024 from 11pm to 12:30am (GMT+1)
Shanghai : Wednesday, March 20th 2024 from 12am to 01:30am (GMT+1)
Tokyo : Wednesday, March 20th 2024 from 01am to 02:30am (GMT+1)
Sydney : Wednesday, March 20th 2024 from 02am to 03:30am (GMT+1)
Wellington : Wednesday, March 20th 2024 from 04am to 05:30am (GMT+1)

Prise en charge actuelle pour les cancers du sein triples négatifs métastatiques

Les webinars du réseau FEM-NET

Share
Thursday, February 1st 2024 from 06pm to 07:30pm (GMT+1)
Honolulu : Thursday, February 1st 2024 from 06am to 07:30am (GMT+1)
San Francisco : Thursday, February 1st 2024 from 08am to 09:30am (GMT+1)
New York : Thursday, February 1st 2024 from 11am to 12:30pm (GMT+1)
Buenos Aires : Thursday, February 1st 2024 from 01pm to 02:30pm (GMT+1)
London / Dublin : Thursday, February 1st 2024 from 04pm to 05:30pm (GMT+1)
Paris / Berlin : Thursday, February 1st 2024 from 05pm to 06:30pm (GMT+1)
Istanbul : Thursday, February 1st 2024 from 06pm to 07:30pm (GMT+1)
Moscou / Dubaï : Thursday, February 1st 2024 from 08pm to 09:30pm (GMT+1)
Bangkok : Thursday, February 1st 2024 from 11pm to 12:30am (GMT+1)
Shanghai : Friday, February 2nd 2024 from 12am to 01:30am (GMT+1)
Tokyo : Friday, February 2nd 2024 from 01am to 02:30am (GMT+1)
Sydney : Friday, February 2nd 2024 from 02am to 03:30am (GMT+1)
Wellington : Friday, February 2nd 2024 from 04am to 05:30am (GMT+1)

Prise en charge du cancer du sein métastatique HER2-faible

Cycle d'enseignement - Le cancer du sein

Share
Wednesday, March 13th 2024 from 06pm to 07:30pm (GMT+1)
Honolulu : Wednesday, March 13th 2024 from 06am to 07:30am (GMT+1)
San Francisco : Wednesday, March 13th 2024 from 08am to 09:30am (GMT+1)
New York : Wednesday, March 13th 2024 from 11am to 12:30pm (GMT+1)
Buenos Aires : Wednesday, March 13th 2024 from 01pm to 02:30pm (GMT+1)
London / Dublin : Wednesday, March 13th 2024 from 04pm to 05:30pm (GMT+1)
Paris / Berlin : Wednesday, March 13th 2024 from 05pm to 06:30pm (GMT+1)
Istanbul : Wednesday, March 13th 2024 from 06pm to 07:30pm (GMT+1)
Moscou / Dubaï : Wednesday, March 13th 2024 from 08pm to 09:30pm (GMT+1)
Bangkok : Wednesday, March 13th 2024 from 11pm to 12:30am (GMT+1)
Shanghai : Thursday, March 14th 2024 from 12am to 01:30am (GMT+1)
Tokyo : Thursday, March 14th 2024 from 01am to 02:30am (GMT+1)
Sydney : Thursday, March 14th 2024 from 02am to 03:30am (GMT+1)
Wellington : Thursday, March 14th 2024 from 04am to 05:30am (GMT+1)

Prise en charge du cancer HER2+ métastatique

Cycle d'enseignement - Le cancer du sein

Share
Scroll Up